Morbidity in Newly Diagnosed type2 Diabetes in Adults (MORNDIAB)
Prevalence of Micro and Macroangiopathy in Newly Diagnosed type2 Diabetic Adults in Suburban Area of Algiers
Sponsor: Bab El Oued Teaching Hospital
Listed as NCT02002091, this observational or N/A phase trial focuses on Complications and Type2 Diabetes Mellitus and remains completed. Sponsored by Bab El Oued Teaching Hospital, it has been updated 13 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Sep 2019 — Nov 2020 [monthly]
Completed
-
Oct 2018 — Sep 2019 [monthly]
Completed
-
Jun 2018 — Oct 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bab El Oued Teaching Hospital
- Birtraria Hospital
- Hopital Ain Taya
- Hôpital Mustapha Pacha
- National Institute of public Health, Algeria
- Parnet Hospital
- University of Algiers
For direct contact, visit the study record on ClinicalTrials.gov .